Impact of weight reduction on pericardial adipose tissue and cardiac structure in patients with atrial fibrillation.

Am Heart J

University of Adelaide and Department of Medicine, Royal Adelaide Hospital, Adelaide, Australia; The Population Health Research Institute, Hamilton Health Sciences, and McMaster University, Ontario, Canada.

Published: May 2015


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Obesity and pericardial adipose tissue are independent risk factors for atrial fibrillation (AF) and adverse cardiac structural remodeling. The effect of weight reduction on pericardial adipose tissue and cardiac structure remains unknown.

Methods: We prospectively performed cardiac magnetic resonance imaging on 87 participants with AF undergoing either structured weight management (intervention) or general lifestyle advice (control). We measured pericardial adipose tissue, atrial and ventricular volumes, and myocardial mass at baseline and 12 months.

Results: In total, 69 participants underwent baseline and 12-month follow-up cardiac magnetic resonance imaging (intervention n = 36 and controls n = 33). From baseline to 12 months, weight loss (kg, mean [95% CI]) was greater in the intervention group from 101.5 kg (97.2-105.8 kg) to 86.5 kg (81.2-91.9 kg) as compared with controls from 102.6 kg (97.2-108.1 kg) to 98.7 kg (91.0-106.3 kg) (time-group interaction P < .001). The intervention group showed a reduction in left atrial volumes (mL) from 105.0 mL (98.9-111.1 mL) to 96.4 mL (91.6-101.1 mL), whereas the change in the control group was from 108.8 mL (99.6-117.9 mL) to 108.9 mL (99.8-118.0 mL) (time-group interaction P < .001). There was a decline in pericardial adipose tissue (cm(3)) from 140.9 cm(3) (129.3-152.4 cm(3)) to 118.8 cm(3) (108.1-129.6 cm(3)) and myocardial mass (g) from 137.6 g (128.1-147.2 g) to 123.1 g (114.5-131.7 g) in the intervention group, whereas the change in the control group was from 143.2 cm(3) (124.6-161.7 cm(3)) to 147.2 cm(3) (128.9-165.4 cm(3)) for pericardial adipose tissue and 138.3 g (124.8-151.8 g) to 140.7 g (127.4-154.1 g) for myocardial mass (both variables, time-group interaction P < .001).

Conclusions: Weight reduction results in favorable structural remodeling and a reduction in pericardial adipose tissue burden.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2015.02.008DOI Listing

Publication Analysis

Top Keywords

pericardial adipose
28
adipose tissue
28
weight reduction
12
reduction pericardial
12
myocardial mass
12
intervention group
12
time-group interaction
12
cm3
9
tissue cardiac
8
cardiac structure
8

Similar Publications

From Cushion to Culprit: The Role of Epicardial Adipose Tissue in Cardiovascular Disease.

Heart Lung Circ

September 2025

Baker Heart and Diabetes Institute, Melbourne, Vic, Australia; Victorian Heart Hospital, Melbourne, Vic, Australia; Victorian Heart Institute, Melbourne, Vic, Australia. Electronic address:

Epicardial adipose tissue (EAT) is the layer of fat located between the visceral pericardium and the myocardium. Emerging research has signified its role in the development of various cardiovascular diseases. The pathogenesis is complex, involving various bioactive compounds that have been implicated in the development of coronary artery disease, heart failure, and arrhythmogenesis.

View Article and Find Full Text PDF

Background: Incretin-based therapies are used to treat type 2 diabetes and obesity, but the presence of diabetes diminishes the magnitude of weight loss produced by these drugs in people with obesity. It is not known whether this attenuated weight change is relevant to the clinical benefits of these drugs in heart failure.

Objectives: The goal of this study was to assess the influence of diabetes on the efficacy and safety of tirzepatide in the SUMMIT trial.

View Article and Find Full Text PDF

Obesity is strongly associated with an increased risk of heart failure. Recent studies indicate that epicardial adipose tissue plays a critical role in the development of obesity-related cardiomyopathy. This distinct visceral fat depot, located between the myocardium and the visceral pericardium, is involved in direct cross-talk with the adjacent myocardium, influencing both its structural integrity and electrophysiological function.

View Article and Find Full Text PDF

Editorial for "Age-, Body Surface Area-, and Sex-Specific Reference Values for Pericardial Adipose Tissue in Children: An MRI Study".

J Magn Reson Imaging

August 2025

Department of Pediatric Cardiology, Instituto de Cardiologia e Transplantes Do Distrito Federal, Brasília, Brazil.

View Article and Find Full Text PDF